Libivirumab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | Hepatitis B surface antigen |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| Chemical and physical data | |
| Formula | C6598H10232N1788O2060S46 |
| Molar mass | 149039.65 g·mol−1 |
  (what is this?) (verify) | |
Libivirumab is a human monoclonal antibody directed against the hepatitis B virus.[1][2]
References
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |